Trial intelligence / Profile preview

H1N1 Vaccine in HIV-Infected Pregnant Women

NCT00992017Phase 2Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Start
Oct 2009
Primary completion
Nov 2010
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

A Phase 2 trial of Influenza A (H1N1) vaccine in influenza A H1N1 infection (H1N1), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2009; status: completed.

02

Drugs

Influenza A (H1N1) vaccine
03

Conditions

influenza A H1N1 infection (H1N1)

Beyond the preview

Go deeper on NCT00992017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00992017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call